https://www.selleckchem.com/products/pri-724.html
Yet no statistically significant difference was found between the two groups in 3-year overall or recurrence-free survival. Patients with EMAST-negative/MSI-H CRC seem to have different clinicopathological characteristics. Future large-scale studies could clarify the role of EMAST genotype as a sub-classifier of MSI-H CRC. Patients with EMAST-negative/MSI-H CRC seem to have different clinicopathological characteristics. Future large-scale studies could clarify the role of EMAST genotype as a sub-classifier of MSI-H CRC.Although an exten
Like
Comment
Share
